Unser Firmenprofil

Breath is a German/US Biotech company specializing in first-in-class therapies for rare respiratory diseases with fatal outcome and high unmet medical need. For its clinical development, the Company is using new proprietary drug formulations optimized for inhaled administration with exclusively licensed, high performance nebulizers. Breath is focusing on integrated therapy solutions in the interaction between diagnostics, therapeutics and eHealth therapy monitoring.